Evaluation of Screening Program for Hepatocellular Carcinoma at a Single Center

El-Azab Ahmed GI, Ahmed El-Helw GA, Ahmed El-Sabawy MM, Samy Kohla MA and Muhammed Omar YA

Department of Hepatology & Gastroenterology, National Liver Institute - Menoufia University, Egypt
Department of Medicine, Mansoura University, Egypt

^*Correspondance to: Mohamed Kohla 

 PDF  Full Text Research Article | Open Access

Abstract:

Background: Hepatocellular Carcinoma (HCC) is the seventh most common cancer in the world is, a form of liver cancer that starts in the cells of the liver. The best way to increase the chances of survival for people at high risk for HCC is to detect it early through regular monitoring. For monitoring purposes, it is recommended to conduct ultrasound exams every four to six months, sometimes in combination with alpha-fetoprotein tests. Aim of the Work: Assess the HCC surveillance and its ability to detect HCC patients early on and improve their management. Patients and Methods: The study involved 300 patients of Hepatocellular Carcinoma (HCC) investigated at Menoufia University's the Institute of National Liver in Egypt. Patients were evaluated using the Liver Cancer of Barcelona Clinic (BCLC) staging system. Furthermore, the patients were classified into three surveillance categories: No surveillance, routine surveillance, and sporadic surveillance. Results: A substantial difference statistically among the groups that received and did not receive surveillance with consideration for the stage of Hepatocellular Carcinoma (HCC) in particular was found. Patients who were observed usually got their diagnoses earlier. Those who were not under surveillance frequently had advanced cases of Hepatocellular Carcinoma upon diagnosis (HCC). Conclusion: High-risk patients were regular investigated for having HCC is necessary for early disease detection, appropriate therapy, and improved survival. Consistent monitoring with AFP and ultrasound allows for early detection of HCC.

Keywords:

HCC; Surveillance; Screening; AFP

Cite the Article:

El-Azab Ahmed GI, Ahmed El-Helw GA, Ahmed El-Sabawy MM, Samy Kohla MA, Muhammed Omar YA. Evaluation of Screening Program for Hepatocellular Carcinoma at a Single Center. Clin Oncol. 2024;9:2100..